The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Theralase Technologies Inc
F:TTX
|
CA |
|
R
|
Rhom Bho Property PCL
SET:TITLE
|
TH |
|
F
|
FirstGroup PLC
DUS:FGR
|
UK |
|
B
|
Banca Generali SpA
XMUN:B7A
|
IT |
|
C
|
Citigroup Inc
BMV:C
|
US |
|
B
|
Business Engineering Corp
XMUN:TBY
|
JP |
|
Accor SA
F:ACR1
|
FR |
|
P
|
Pico Far East Holdings Ltd
OTC:PCOFF
|
HK |
|
DSV A/S
F:DS81
|
DK |
|
T
|
Tsodilo Resources Ltd
XMUN:TZO
|
CA |
|
Portmeirion Group PLC
OTC:POTMF
|
UK |
|
Iren SpA
F:TZ8
|
IT |
|
Total Bangun Persada Tbk PT
F:T9Q
|
ID |
|
Grodno SA
F:WO7
|
PL |
|
A
|
AI/ML Innovations Inc
XMUN:42FB
|
CA |
|
CDN Maverick Capital Corp
F:338B
|
CA |
|
StarragTornos Group AG
SIX:STGN
|
CH |
|
SABIC Agri-Nutrients Company SJSC
SAU:2020
|
SA |
|
Art's Way Manufacturing Co Inc
F:ID2
|
US |
|
R
|
Revitalist Lifestyle and Wellness Ltd
F:4DO
|
US |
|
P
|
Pexip Holding ASA
XMUN:4W9
|
NO |
|
C
|
Credit Acceptance Corp
F:2D5
|
US |
|
Daiwa Securities Group Inc
F:DSE
|
JP |
|
D
|
Defence Therapeutics Inc
F:DTC
|
CA |
Theralase Technologies Inc (TTX)’s 12-month stock price forecast through October 2027 has a consensus target of €0.4733, implying 376% upside. The forecast is based on price targets from 3 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
TTX is 0.4733 EUR with a low forecast of 0.4686 EUR and a high forecast of 0.4872 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been -6%. The projected CAGR for the next 3 years is 355%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been -7%. The projected CAGR for the next 3 years is 338%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more